help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2004-0279
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nguyen, B. T.
Right arrow Articles by Dessauer, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nguyen, B. T.
Right arrow Articles by Dessauer, C. W.
Molecular Endocrinology 19 (4): 1012-1023
Copyright © 2005 by The Endocrine Society

Relaxin Stimulates Protein Kinase C {zeta} Translocation: Requirement for Cyclic Adenosine 3',5'-Monophosphate Production

Bao T. Nguyen and Carmen W. Dessauer

Department of Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston, Houston, Texas 77030

Address all correspondence and requests for reprints to: Carmen W. Dessauer, Department of Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, Texas 77030. E-mail: Carmen.W.Dessauer{at}uth.tmc.edu.

Relaxin is a polypeptide hormone that activates the leucine-rich repeat containing G protein-coupled receptors, LGR7 and LGR8. In an earlier study, we reported that relaxin produces a biphasic time course and the second wave of cAMP is highly sensitive to phosphoinositide-3 kinase inhibitors (LY294002 and wortmannin). LY294002 inhibits relaxin-mediated increases in cAMP production by 40–50% across a large range of relaxin concentrations. Here we show that protein kinase C {zeta} (PKC{zeta}) is a component of relaxin signaling in THP-1 cells. Sphingomyelinase increases cAMP production due to the release of ceramide, a direct activator of PKC{zeta}. Chelerythrine chloride (a general PKC inhibitor) inhibits relaxin induced cAMP production to the same degree (~40%) as LY294002. Relaxin stimulates PKC{zeta} translocation to the plasma membrane in THP-1, MCF-7, pregnant human myometrial 1–31, and mouse mesangial cells, as shown by immunocytochemistry. PKC{zeta} translocation is phosphoinositide-3 kinase dependent and independent of cAMP production. Antisense PKC{zeta} oligodeoxynucleotides (PKC{zeta}-ODNs) deplete both PKC{zeta} transcript and protein levels in THP-1 cells. PKC{zeta}-ODNs abolish relaxin-mediated PKC{zeta} translocation and inhibit relaxin stimulation of cAMP by 40%, as compared with mock and random ODN controls. Treatment with LY294002 in the presence of PKC{zeta}-ODNs results in little further inhibition. In summary, we present a novel role for PKC{zeta} in relaxin-mediated stimulation of cAMP.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. E. Shaw, P. Wood, J. Kulpa, F. H. Yang, A. J. Summerlee, and W. G. Pyle
Relaxin alters cardiac myofilament function through a PKC-dependent pathway
Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H29 - H36.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Kern and G. D. Bryant-Greenwood
Characterization of Relaxin Receptor (RXFP1) Desensitization and Internalization in Primary Human Decidual Cells and RXFP1-Transfected HEK293 Cells
Endocrinology, May 1, 2009; 150(5): 2419 - 2428.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. L. Halls, E. T. van der Westhuizen, J. D. Wade, B. A. Evans, R. A. D. Bathgate, and R. J. Summers
Relaxin Family Peptide Receptor (RXFP1) Coupling to G{alpha}i3 Involves the C-Terminal Arg752 and Localization within Membrane Raft Microdomains
Mol. Pharmacol., February 1, 2009; 75(2): 415 - 428.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
K. Heng, R. Ivell, P. Wagaarachchi, and R. Anand-Ivell
Relaxin signalling in primary cultures of human myometrial cells
Mol. Hum. Reprod., October 1, 2008; 14(10): 603 - 611.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. L. Halls, R. A. D. Bathgate, and R. J. Summers
Comparison of Signaling Pathways Activated by the Relaxin Family Peptide Receptors, RXFP1 and RXFP2, Using Reporter Genes
J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 281 - 290.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. L. Halls, R. A. D. Bathgate, and R. J. Summers
Relaxin Family Peptide Receptors RXFP1 and RXFP2 Modulate cAMP Signaling by Distinct Mechanisms
Mol. Pharmacol., July 1, 2006; 70(1): 214 - 226.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Goichberg, A. Kalinkovich, N. Borodovsky, M. Tesio, I. Petit, A. Nagler, I. Hardan, and T. Lapidot
cAMP-induced PKC{zeta} activation increases functional CXCR4 expression on human CD34+ hematopoietic progenitors
Blood, February 1, 2006; 107(3): 870 - 879.
[Abstract] [Full Text] [PDF]


Home page
Clin Med ResHome page
C. S. Samuel
Relaxin: Antifibrotic Properties and Effects in Models of Disease
Clin. Med. Res., November 1, 2005; 3(4): 241 - 249.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society